Targeting of MCL-1 in Breast Cancer-Associated Fibroblasts Reverses Their Myofibroblastic Phenotype and Pro-invasive Properties

The authors showed that pharmacological inhibition or knock down of MCL-1 in primary breast cancer-associated fibroblasts directly derived from human samples mitigated myofibroblastic features.